Targeting of 3D oral cancer spheroids by αVβ6 integrin using near-infrared peptide-conjugated IRDye 680

• Published in: Cancer cell international Vol. 24; no. 1; pp. 228 - 17
• Main Authors: Dirheimer, L, Pons, T, François, A, Lamy, L, Cortese, S, Marchal, F, Bezdetnaya, L
• Format: Journal Article
• Language: English
• Published: England BioMed Central 29-06-2024; BMC
• Subjects: Amino acids; Antibodies; Cancer; Cell culture; Cells; Contrast media; Cytokeratin; E-cadherin; Extracellular matrix; Fibroblasts; Fibronectin; Flow cytometry; Fluorescence; Fluorescence imaging; Fluorescent indicators; Head & neck cancer; Head and neck cancer; Heat; I.R. radiation; Immunofluorescence; Life Sciences; Microscopy; Nanoparticles; Oncology; Oral cancer; Oral carcinoma; Oral cavity; Peptides; Polymers; Spheroid; Spheroids; Squamous cell carcinoma; Stroma; Surgery; Tongue; Tongue cancer; Tumor cell lines; Tumors; Vimentin; Western blotting; αVβ6 integrin; United Kingdom > UK; France; United States > US; Germany; Fluorescence imaging; Oral cancer; Near Infrared fluorescence (NIR); αVβ6 integrin; Head and neck cancer; Tongue cancer; Spheroid; IRDye
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-024-03417-y

In the treatment of oral cavity cancer, margin status is one of the most critical prognostic factors. Positive margins are associated with higher local recurrence and lower survival rates. Therefore, the universal goal of oral surgical oncology is to achieve microscopically clear margins. Near-infrared fluorescence guided surgery (FGS) could improve surgical resection using fluorescent probes. αVβ6 integrin has shown great potential for cancer targeting due to its overexpression in oral cancers. Red fluorescent contrast agent IRDye 680 coupled with anti-αVβ6 peptide (IRDye-A20) represents an asset to improve FGS of oral cancer. This study investigates the potential of IRDye-A20 as a selective imaging agent in 3D three-dimensional tongue cancer cells.
αVβ6 integrin expression was evaluated by RT-qPCR and Western Blotting in 2D HSC-3 human tongue cancer cells and MRC-5 human fibroblasts. Targeting ability of IRDye-A20 was studied in both cell lines by flow cytometry technique. 3D tumor spheroid models, homotypic (HSC-3) and stroma-enriched heterotypic (HSC-3/MRC-5) spheroids were produced by liquid overlay procedure and further characterized using (immuno)histological and fluorescence-based techniques. IRDye-A20 selectivity was evaluated in each type of spheroids and each cell population.
αVβ6 integrin was overexpressed in 2D HSC-3 cancer cells but not in MRC-5 fibroblasts and consistently, only HSC-3 were labelled with IRDye-A20. Round shaped spheroids with an average diameter of 400 μm were produced with a final ratio of 55%/45% between HSC-3 and MRC-5 cells, respectively. Immunofluorescence experiments demonstrated an uniform expression of αVβ6 integrin in homotypic spheroid, while its expression was restricted to cancer cells only in heterotypic spheroid. In stroma-enriched 3D model, Cytokeratin 19 and E-cadherin were expressed only by cancer cells while vimentin and fibronectin were expressed by fibroblasts. Using flow cytometry, we demonstrated that IRDye-A20 labeled the whole homotypic spheroid, while in the heterotypic model all cancer cells were highly fluorescent, with a negligible fluorescence in fibroblasts.
The present study demonstrated an efficient selective targeting of A20FMDV2-conjugated IRDye 680 in 3D tongue cancer cells stroma-enriched spheroids. Thus, IRDye-A20 could be a promising candidate for the future development of the fluorescence-guided surgery of oral cancers.